SCHEMBL25539769

SCHEMBL25539769

CC1(C)c2c(cccc2-c2ccc(-c3nc(-c4ccccc4)cc(-c4ccc(-c5ccccc5)cc4)n3)c3ccccc23)-c2ccc3ccccc3c21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 1/20 0.38
CYP1A1 P04798 1/20 0.38
CYP1B1 Q16678 1/20 0.38
MEN1 O00255 9/20 0.37
KMT2A Q03164 9/20 0.37
ALDH1A1 P00352 8/20 0.37
MAPT P10636 8/20 0.37
HPGD P15428 8/20 0.37
KDM4E B2RXH2 6/20 0.37
NTSR1 P30989 1/20 0.37
PIM1 P11309 1/20 0.37
CYP2C19 P33261 2/20 0.36
ACACA Q13085 1/20 0.36
ENPP3 O14638 1/20 0.36
ENPP1 P22413 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
TP53 P04637 2/20 0.36
HSD17B10 Q99714 2/20 0.36
TDP1 Q9NUW8 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25539774 1.00 DHODH (0.38) DHODHCYP1A1CYP1B1MEN1KMT2A
SCHEMBL25540491 1.00 DHODH (0.38) DHODHCYP1A1CYP1B1MEN1KMT2A
SCHEMBL25540333 1.00 DHODH (0.38) DHODHCYP1A1CYP1B1MEN1KMT2A
SCHEMBL25539866 0.97 CA12 (0.37) DHODHCYP1A1CYP1B1MEN1KMT2A
SCHEMBL25539768 0.97 HPGD (0.39) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL25540332 0.97 HPGD (0.39) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL25540492 0.96 MEN1 (0.40) DHODHCYP1A1CYP1B1MEN1KMT2A
SCHEMBL25540486 0.96 CYP1A1 (0.38) DHODHCYP1A1CYP1B1MEN1KMT2A
SCHEMBL25539776 0.96 CYP1A1 (0.38) DHODHCYP1A1CYP1B1MEN1KMT2A
SCHEMBL25538415 0.96 MEN1 (0.40) DHODHCYP1A1CYP1B1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, L1CAM DHODH 2394/4885CYP1A1 888/4885CYP1B1 1273/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.